S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
What is a Gold IRA, and is it a Viable Investment?
The "King Of Quants" sees 10X potential... (Ad)
Closing prices for crude oil, gold and other commodities
UN body mulls deep sea mining amid demand for minerals
The "King Of Quants" sees 10X potential... (Ad)
MarketBeat Week in Review – 3/27 - 3/31
Canada approves largest telecom deal in country's history
Biden's corruption knows no end (Ad)pixel
Intensity and insults rise as lawmakers debate debt ceiling
Medicare, Social Security could fall short over next decade
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
What is a Gold IRA, and is it a Viable Investment?
The "King Of Quants" sees 10X potential... (Ad)
Closing prices for crude oil, gold and other commodities
UN body mulls deep sea mining amid demand for minerals
The "King Of Quants" sees 10X potential... (Ad)
MarketBeat Week in Review – 3/27 - 3/31
Canada approves largest telecom deal in country's history
Biden's corruption knows no end (Ad)pixel
Intensity and insults rise as lawmakers debate debt ceiling
Medicare, Social Security could fall short over next decade
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
What is a Gold IRA, and is it a Viable Investment?
The "King Of Quants" sees 10X potential... (Ad)
Closing prices for crude oil, gold and other commodities
UN body mulls deep sea mining amid demand for minerals
The "King Of Quants" sees 10X potential... (Ad)
MarketBeat Week in Review – 3/27 - 3/31
Canada approves largest telecom deal in country's history
Biden's corruption knows no end (Ad)pixel
Intensity and insults rise as lawmakers debate debt ceiling
Medicare, Social Security could fall short over next decade
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
What is a Gold IRA, and is it a Viable Investment?
The "King Of Quants" sees 10X potential... (Ad)
Closing prices for crude oil, gold and other commodities
UN body mulls deep sea mining amid demand for minerals
The "King Of Quants" sees 10X potential... (Ad)
MarketBeat Week in Review – 3/27 - 3/31
Canada approves largest telecom deal in country's history
Biden's corruption knows no end (Ad)pixel
Intensity and insults rise as lawmakers debate debt ceiling
Medicare, Social Security could fall short over next decade
OTCMKTS:TMED

Trimedyne - TMED Stock Forecast, Price & News

$4.25
-0.01 (-0.23%)
(As of 03/20/2020)
Add
Compare
Today's Range
$4.25
$4.25
50-Day Range
$4.25
$4.25
52-Week Range
$3.48
$7.00
Volume
100 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

TMED stock logo

About Trimedyne (OTCMKTS:TMED) Stock

Trimedyne, Inc. manufactures and sells lasers, and disposable and reusable fiber-optic laser devices for use in the medical field. It offers lasers, fibers, needles, and switch tips for use in orthopedics, urology, ear and nose surgery, throat surgery, gynecology, gastrointestinal surgery, general surgery, and other medical specialties. The company also provides 80 watt and 30 watt holmium lasers, and side firing laser needles to treat herniated or ruptured spinal discs. In addition, it engages in the provision of services, and rental of lasers and other medical equipment to hospitals and surgery centers on a fee-per-case basis. The company operates in Asia, Europe, Latin America, the Middle East, Australia, and internationally. It markets its products through commission sales representatives in the United States and independent distributors internationally. Trimedyne, Inc. was founded in 1980 and is based in Irvine, California.

Receive TMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trimedyne and its competitors with MarketBeat's FREE daily newsletter.

TMED Stock News Headlines

EGF Theramed Health Closes Tranche of Financing
Bear market expert makes new prediction
Nobody believed Larry Benedict's prediction in February 2020. The DOW plunged 3.5%, and he told CNBC, "It seems like there's much more to come." Within a month, the market plummeted 34%. Then, nobody believed Larry at the start of last year, either. He predicted that "all the indexes will be negative for the year," with the Nasdaq leading the way. Once again, he was spot-on.
Trimedyne, Inc. (TMED)
Trimedyne Reports Its Financial Results for the...
Bear market expert makes new prediction
Nobody believed Larry Benedict's prediction in February 2020. The DOW plunged 3.5%, and he told CNBC, "It seems like there's much more to come." Within a month, the market plummeted 34%. Then, nobody believed Larry at the start of last year, either. He predicted that "all the indexes will be negative for the year," with the Nasdaq leading the way. Once again, he was spot-on.
Trimedyne Mourns the Death of Marvin P. Loeb
See More Headlines
Receive TMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trimedyne and its competitors with MarketBeat's FREE daily newsletter.

TMED Company Calendar

Last Earnings
2/20/2018
Today
4/01/2023
Fiscal Year End
9/30/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
OTCMKTS:TMED
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Glenn D. Yeik (Age 51)
    Interim Chairman, CEO & Pres
  • Mr. Brian T. Kenney (Age 62)
    VP of Global Sales & Marketing













TMED Stock - Frequently Asked Questions

How have TMED shares performed in 2023?

Trimedyne's stock was trading at $4.25 at the beginning of the year. Since then, TMED stock has increased by 0.0% and is now trading at $4.25.
View the best growth stocks for 2023 here
.

How were Trimedyne's earnings last quarter?

Trimedyne, Inc. (OTCMKTS:TMED) posted its quarterly earnings data on Tuesday, February, 20th. The technology company reported $0.70 EPS for the quarter. The technology company earned $1.53 million during the quarter.

What other stocks do shareholders of Trimedyne own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trimedyne investors own include Aflac (AFL), Diana Shipping (DSX), Cohen & Steers Closed-End Opportunity Fund (FOF), Incyte (INCY), National Fuel Gas (NFG), PDC Energy (PDCE), The Rank Group (RNK), Safehold (SAFE), Snap (SNAP) and Aramark (ARMK).

What is Trimedyne's stock symbol?

Trimedyne trades on the OTCMKTS under the ticker symbol "TMED."

How do I buy shares of Trimedyne?

Shares of TMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Trimedyne's stock price today?

One share of TMED stock can currently be purchased for approximately $4.25.

How can I contact Trimedyne?

Trimedyne's mailing address is 5 HOLLAND BLDG #223, IRVINE CA, 92618. The official website for the company is www.trimedyne.com. The technology company can be reached via phone at 949-951-3800 or via fax at 949-855-8206.

This page (OTCMKTS:TMED) was last updated on 4/1/2023 by MarketBeat.com Staff